Treatment options for central nervous system lymphomas in immunocompetent patients.
about
Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience.Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphomaPituitary stalk lesions: systematic review and clinical guidance.Immune adaptive microenvironment profiles in intracerebral and intrasplenic lymphomas share common characteristics.Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.
P2860
Treatment options for central nervous system lymphomas in immunocompetent patients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Treatment options for central nervous system lymphomas in immunocompetent patients.
@ast
Treatment options for central nervous system lymphomas in immunocompetent patients.
@en
Treatment options for central nervous system lymphomas in immunocompetent patients.
@nl
type
label
Treatment options for central nervous system lymphomas in immunocompetent patients.
@ast
Treatment options for central nervous system lymphomas in immunocompetent patients.
@en
Treatment options for central nervous system lymphomas in immunocompetent patients.
@nl
prefLabel
Treatment options for central nervous system lymphomas in immunocompetent patients.
@ast
Treatment options for central nervous system lymphomas in immunocompetent patients.
@en
Treatment options for central nervous system lymphomas in immunocompetent patients.
@nl
P2860
P356
P1476
Treatment options for central nervous system lymphomas in immunocompetent patients.
@en
P2093
Eckhard Thiel
Kristoph Jahnke
P2860
P304
P356
10.1586/ERN.09.100
P577
2009-10-01T00:00:00Z